Home > Back to Publisher > Report Information

Advances in Biopharmaceutical Technology in India

BioPlan Associates, Inc.
January 1, 2008
766 Pages - SKU: DFAQ1666473

Abstract Table of Contents Related Reports

Countries covered: India

INDIA is rapidly becoming a vital, mature partner within international bio/pharmaceutical markets. The new peer-reviewed, joint Society for Industrial Microbiology publication, Advances in Biopharmaceutical Technology in India, indicates that Indian companies and suppliers plan to achieve a 10% global biopharmaceutical market share within the foreseeable future.

This study provides an in-depth view of the biopharmaceutical industry in India. It describes the current state of technology, partnership opportunities, science aspects, and general business practices. Readers will find accurate, peer-reviewed analysis of business opportunities to help them create effective India Strategies.

By the Numbers:

35 Internationally Recognized Authors
766 Pages
20 Chapters
14 Peer reviewers
1,178 References
118 Tables and 49 Figures

What You'll Get:

Expert, unbiased, analysis: 35 internationally recognized authors, sponsored by Society for Industrial Microbiology
Peer-reviewed: Editorial board and review ensures relevance, accuracy, and substance.
Unparalleled access to experts: Purchasers have unique access to study contributors and authors.
Fresh, relevant information: Subject matter experts combine their in-depth knowledge with current, primary data.

India is investing heavily in technologies and education, and will be one of the world's largest markets for vaccines and biopharmaceuticals.

This comprehensive study of the science and business of biopharmaceuticals in India: Advan ces in Biopharmaceutical Technology in India provides answers, from world- recognized subject matter experts in India, the US, and Europe.

Advances in Biopharmaceutical Technology in INDIA:
describes the Indian industry, organizations, and government plans and goals. It details successes, problems, and gaps. The study covers issues critical to biomanufacturers, CMOs, CROs, and suppliers, and describes the current state of technology, partnership opportunities, and general business practices.

A ready reference for all aspects of biopharmaceuticals in India
India has one of the world's fastest growing economies, and the second-largest population, with 1.1 billion people. Its middle class is the engine providing the economic power to support an expanding domestic healthcare industry. Learn how to take advantage of the opportunities that exist for organizations that establish solid business and scientific strategies.

PART 1: Introduction: Chapter 1 Prospects for Modern Biotechnology in India
PART 2: State of India's Life Sciences Industry: Chapter 2 A Window into India's Biopharma Sector; Chapter 3 Indian Biopharmaceutical System and Policies; Chapter 4 Government Support for Biotech and Biopharmaceuticals Industry; Chapter 5 Biopharmaceutical Products in India.; Chapter 6 Biogeneric Manufacturing in India; Chapter 7 Biopharmaceutical Market Situation.; Chapter 8 The Contract Research Industry in India; Chapter 9 Regulatory Landscape for Clinical Trials in India; INDIA BRIEF 1 Pre-Clinical and Clinical Trial in India; Chapter 10 Life Sciences Education in India
PART 3: Scientific Issues in India: Chapter 11 Vaccine Industry in India; Chapter 12 Development of Plasma-Derived Biopharmaceuticals in India: Challenges and Opportunities; Chapter 13 Bioprocess Expression and Production Technologies in India; INDIA BRIEF 2 Technology Transfer: Impact and Importance for Indian Biotechnology Growth; Chapter 14 Application of Recent Advances in Immunology for Developing Novel Biotherapeutics in India; Chapter 15 Early-stage Key R&D Components for Successful Development of Protein Therapeutics; Chapter 16 Understanding Ayurveda Medicine
PART 4: Biobusiness in India: Chapter 17 Biopharmaceutical Outsourcing: A Overview--India and China; Chapter 18 Biopharmaceutical Research Collaborations between India and the West: Prospective Partnerships; Chapter 19 Outsourcing R&D to India; INDIA BRIEF 3 Outsourcing Biopharma R&D to India; Chapter 20 Venture Capital in India Today
Organizations Represented (Authors): Amgen, Inc.; Apothecaries Ltd.; beòcarta Ltd.; Bharat Biotech International Ltd.; BioPlan Associates, Inc.; Biospectrum Asia; Cadila Pharmaceuticals Ltd.; CanBiotech; Celestial Biologicals Ltd; Chiltern International Private Ltd.; Dow AgroSciences LLC; Endocrine Technology, LLC; Finston Consulting, LLC; GAEA Resources Inc.; Health Interactions; J. Sagar Associates; John Curling Consulting AB; M J Biopharm Pvt. Ltd.; Magnetical; National Institute of Health; National Institute of Science Technology and Development Studies; Neo BioMed Services; ProMetic BioTherapeutics, Inc.; Serum Institute of India Ltd.; Strategic Manufacturing Worldwide, Inc.; Uniformed Services University of the Health Sciences.
Reviewers from:: Bharat Biotech, India; Biotech Consultant LLC, USA; Cadila Pharmaceuticals Ltd., India; Excel Life Sciences, Inc., USA; Falconridge Associates, Inc.; Institute of Bioinformatics and Applied Biotechnology (IBAB), India; John Curling Consulting, Sweden; Madhav Institute of Technology and Science, India; National Institute of Science Technology and Development Studies, India; Newport Biotech; Strategic Manufacturing Worldwide, Inc.; University of Illinois, USA; University of Iowa, USA

More India Biopharmaceuticals Reports

Strategic Analysis of Indian Biosimilar Market by Frost & Sullivan
This research deliverable provides deep insights into the Biosimilar market in India. It also includes an overview of the Indian regulatory and R&D process briefing ...

Bringing Biologics to Market in the BRIC Countries by Decision Resources
Pharmaceutical companies are realizing the lucrative opportunities for growth offered by biologics because these high-priced drugs can target growing niche markets, compensate for dwindling pipelines, ...

The 2009-2014 Outlook for Biologics in India by Icon Group International, Inc.
This econometric study covers the latent demand outlook for biologics across the states, union territories and cities of India. Latent demand (in millions of U.S. ...

Directory of Top 60 Biopharmaceutical Manufacturers in INDIA by BioPlan Associates, Inc.
A comprehensive industry review: profiles of the established, and rapidly growing, organizations involved in ...

New Directory: Top 60 Biopharmaceutical Manufacturers in INDIA by BioPlan Associates, Inc.
The first edition of the BioPlan India Biopharmaceutical Index includes the Top 60 Biopharmaceutical Companies in India, with detailed profiles of their business focus, products, ...

See all reports like this >>

More India Reports

D&B Country RiskLine Report: India by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country Report: India by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Country Report India January 2011 by Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...

India: Country Profile by MarketLine
INTRODUCTION This report provides a detailed analysis on India, providing an overview of its political, economic and business environment, represented both textually and in graph and ...

2007 India Industry & Market Outlook report by Barnes Reports
The 2007 India Industry & Market Outlook report is the leading annual publication that describes over 100 major industries in India and 500+ minor industries ...

See all reports like this >>

Advances in Biopharmaceutical Technology in India

Share this report

Other tasks

Research Assistance

Related Markets

Biopharmaceuticals Reports

Free Alert Me service